Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.

Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, McGeer A, Raboud J, Scales DC, Gojovic MZ, Krahn M.

Vaccine. 2010 Aug 31;28(38):6210-20. doi: 10.1016/j.vaccine.2010.07.010.

PMID:
20643091
2.

Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW.

Fizzell J, Campbell-Lloyd S, Hallett AJ, Lowbridge CP, Meijer D, Tyner SE.

N S W Public Health Bull. 2010 Jan-Feb;21(1-2):32-5. doi: 10.1071/NB09039.

3.

Vaccines against influenza A (H1N1) pandemic.

Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008.

PMID:
20304259
4.

Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden.

Brouwers L, Cakici B, Camitz M, Tegnell A, Boman M.

Euro Surveill. 2009 Sep 17;14(37). pii: 19333.

5.

Summaries for patients. Assessing the best way to prevent spread of influenza.

[No authors listed]

Ann Intern Med. 2009 Dec 15;151(12):I31. doi: 10.7326/0003-4819-151-12-200912150-00161. No abstract available.

PMID:
20008744
6.

Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.

Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK.

Ann Intern Med. 2009 Dec 15;151(12):829-39. doi: 10.7326/0003-4819-151-12-200912150-00157.

7.

A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics.

Cho BH, Hicks KA, Honeycutt AA, Hupert N, Khavjou O, Messonnier M, Washington ML.

J Public Health Manag Pract. 2011 Jan-Feb;17(1):E22-8. doi: 10.1097/PHH.0b013e3181f87952.

PMID:
21135651
8.

Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.

Huang WT, Chen WW, Yang HW, Chen WC, Chao YN, Huang YW, Chuang JH, Kuo HS.

Vaccine. 2010 Oct 18;28(44):7161-6. doi: 10.1016/j.vaccine.2010.08.069.

PMID:
20804804
9.

Modelling mitigation strategies for pandemic (H1N1) 2009.

Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT.

CMAJ. 2009 Nov 10;181(10):673-80. doi: 10.1503/cmaj.091641.

10.

Cost-effectiveness of Ontario's pandemic vaccine program.

Rolland-Harris E, Tepper M.

Vaccine. 2011 May 17;29(22):3829; author reply 3830-1. doi: 10.1016/j.vaccine.2010.08.089. No abstract available.

PMID:
20831912
11.

Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.

Seale H, Kaur R, Wang Q, Yang P, Zhang Y, Wang X, Li X, Zhang H, Zhang Z, MacIntyre CR.

Vaccine. 2011 Feb 11;29(8):1605-10. doi: 10.1016/j.vaccine.2010.12.077.

PMID:
21211593
12.

Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian Experience.

Sander B, Bauch C, Fisman DN, Fowler R, Kwong JC, McGeer A, Zivkovic Gojovic M, Krahn M.

PLoS Curr. 2009 Dec 17;1:RRN1137.

13.

Optimal pandemic influenza vaccine allocation strategies for the Canadian population.

Tuite AR, Fisman DN, Kwong JC, Greer AL.

PLoS One. 2010 May 6;5(5):e10520. doi: 10.1371/journal.pone.0010520.

14.

Pandemic influenza H1N1 2009--the Canadian experience.

Scott K.

J Popul Ther Clin Pharmacol. 2010 Fall;17(3):e358-62.

PMID:
21041869
15.

The health care response to pandemic influenza.

American College of Physicians., Barnitz L, Berkwits M.

Ann Intern Med. 2006 Jul 18;145(2):135-7.

PMID:
16801625
16.

Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public.

Eastwood K, Durrheim DN, Jones A, Butler M.

Med J Aust. 2010 Jan 4;192(1):33-6.

PMID:
20047546
17.

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.

Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002.

PMID:
20096762
18.

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.

Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, Yu R, Zhangzhu J, Liu W, Zeng Y, Li X, Zhang X, Pang X, Deng Y.

N Engl J Med. 2010 Dec 16;363(25):2416-23. doi: 10.1056/NEJMoa1006736.

19.

Poverty, wealth, and access to pandemic influenza vaccines.

Yamada T.

N Engl J Med. 2009 Sep 17;361(12):1129-31. doi: 10.1056/NEJMp0906972. No abstract available.

20.

A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.

Pereira JA, Foisy J, Kwong JC, Heidebrecht CL, Quach S, Quan SD, Guay M, Sander B; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group..

BMC Health Serv Res. 2011 Sep 1;11:210. doi: 10.1186/1472-6963-11-210.

Items per page

Supplemental Content

Support Center